Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01000558 · ClinicalTrials.gov registry record

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

A clinical trial of Lymphoma, sponsored by SWOG Cancer Research Network.

Completed
Registry status
939
Enrollment target
20
Study locations

NCT01000558 is a study of Lymphoma that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 939 participants, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01000558, a study of Lymphoma, has completed, sponsored by SWOG Cancer Research Network.

COMPLETED
Registry status
939 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.

Conditions Studied

Interventions

  • OTHER biologic sample preservation procedure

Study Locations (20)

Georgia

  • Piedmont Hospital - Atlanta
  • Northside Hospital Cancer Center - Atlanta
  • Saint Joseph's Hospital of Atlanta - Atlanta
  • CCOP - Atlanta Regional - Atlanta
  • WellStar Cobb Hospital - Austell
  • John B. Amos Cancer Center - Columbus
  • Charles B. Eberhart Cancer Center at DeKalb Medical Center - Decatur
  • Piedmont Fayette Hospital - Fayetteville

California

  • Alta Bates Summit Comprehensive Cancer Center - Berkeley
  • Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center - Burbank
  • Peninsula Medical Center - Burlingame
  • North Bay Cancer Center - Fairfield
  • California Pacific Medical Center - California Campus - San Francisco
  • Sutter Health - Western Division Cancer Research Group - San Rafael
  • Sutter Solano Medical Center - Vallejo

Alabama

  • Providence Cancer Center at Providence Hospital - Mobile

Alaska

  • Alaska Regional Hospital Cancer Center - Anchorage

Arkansas

  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center - Fort Smith

Connecticut

  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center - Hartford

Florida

  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 939 participants
Start Date 2005-03
Est. Completion 2011-07

Sponsor

SWOG Cancer Research Network

270 total trials

What the Registry Record Tells You About NCT01000558

The ClinicalTrials.gov registry entry for NCT01000558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 939 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (95% higher). The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.

NCT01000558 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Georgia, California, Alabama.

Frequently Asked Questions

What is clinical trial NCT01000558 about?

NCT01000558 is a clinical study titled "SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma". RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.

What is the current status of trial NCT01000558?

This trial is currently completed. The enrollment target is 939 participants. The study started on 2005-03. Estimated completion is 2011-07.

What conditions does trial NCT01000558 study?

This clinical trial studies the following conditions: Lymphoma.

What interventions are being tested in trial NCT01000558?

The interventions under investigation include: biologic sample preservation procedure (OTHER).

Who is sponsoring clinical trial NCT01000558?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01000558 being conducted?

This trial has 20 study locations across Alabama, Alaska, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.